期刊文献+

益气养阴、活血解毒法对冠心病患者血管内皮损伤、血小板活化及炎症因子的影响 被引量:21

Effect of Reinforcing Qi,Replenishing Yin,Activating Blood and Removing Toxins on the Endothelial Injury of Vessels,Platelet Activation and Inflammatory Factor in Coronary Heart Disease Patients
在线阅读 下载PDF
导出
摘要 目的探讨益气养阴、解毒活血组方对冠心病患者血小板活化、内皮功能紊乱和炎症反应相关指标的影响。方法将86例冠心病患者随机分为益气养阴、活血解毒组(治疗1组)、益气养阴组(治疗2组)及对照组,观察患者治疗前后血浆中血管性假性血友病因子(vWF)、α颗粒膜蛋白140(GMP-140)、血清C反应蛋白(CRP)和肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)含量变化。结果治疗后治疗1组vWF、GMP-140、CRP、TNF-α、IL-6含量均明显低于其他组(P<0.05)。结论益气养阴、解毒活血方治疗冠心病能起到改善其内皮细胞损伤、抑制血小板活化、抗动脉炎症反应、改善动脉硬化的作用。 Objective To study the effect of prescriptions of reinforcing qi,replenishing yin,activating blood and removing toxins on the platelet activation,vessel endothelial disorders and inflammatory reactions in coronary heart disease patients. Methods The 86 patients were randomized into the group of reinforcing qi,replenishing yin,activating blood and removing toxins (treatment group 1), the group of reinforcing qi and replenishing yin (treatment group 2),and the control group. Before and after treatment,the level of plasma von willebrand factor (vWF),alpha-granular membrane protein (α-GMP-140),serum C-reactive protein (CRP),tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) was measured respectively. Results After treatment, vWF,α GMP-140,CRP,TNF-α and IL-6 of treatment group 1 were significantly lowered than those of other groups(P〈0. 05). Conclusion The prescriptions of reinforcing qi,replenishing yin,activating blood and removing toxins can obviously repair the endothelial injuries,inhibit the platelet activation ,resist the arterial inflammatory reactions ,and improve the arteriosclerosis.
出处 《中医杂志》 CSCD 北大核心 2008年第4期317-319,共3页 Journal of Traditional Chinese Medicine
关键词 血管性假性血友病因子 α颗粒膜蛋白140 C反应蛋白 肿瘤坏死因子 白细胞介素6 益气养阴 活血解毒 von willebrand factor (vWF)i alpha-granular membrane protein (a-GMP-140)~ Serum C-reactive protein (CRP)~ Tu-mor necrosis factor-α (TNF-α) Interleukin 6 (IL-6) Reinforcing qi,replenishing yin,activatining blood and removing toxins
  • 相关文献

参考文献9

二级参考文献19

  • 1张希颐,王常卿,马金亭,牛平光,何娟.循环和组织的血管紧张素系统的研究进展[J].国外医学(临床生物化学与检验学分册),1994,15(1):24-26. 被引量:1
  • 2陈伟,何燕,林钟香,肖沪生,陈长勋.舒心饮改善冠心病左心室舒张功能障碍的临床研究[J].中国中西医结合杂志,1995,15(5):271-273. 被引量:19
  • 3石如海,祝善俊,杨映波,冯素珍,徐有奇.冠心病患者内皮细胞损伤后的功能变化及卡托普利的干预作用[J].临床心血管病杂志,1995,11(4):195-198. 被引量:9
  • 4汪晓云,李必瑶,孙小平,卢薇,周群,廖昆灵.夏方丹参注射液对冠心病患者临床疗效及肾素-血管紧张素系统的影响[J].中国中西医结合杂志,1997,17(1):53-54. 被引量:26
  • 5Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies : Part I. Circulation, 2003,108 : 1664-1672.
  • 6Shebuski R J, Kilgore KS. Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther, 2002,300 : 729-735.
  • 7Carter AM, Anagnostopoulou K, Mansfield MW, et al. Soluble P-selectin levels, P-selectin polyrnorphisms and cardiovascular disease. J Thromb Haemost,2003,1 : 1718-1723.
  • 8Braunwald E, Antman EM, Beasley JW, et ah ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2000, 36:970-1062.
  • 9Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983,51 : 606.
  • 10Smith SC, Dove JT, Jacobs AK, et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( committee to revise the 1993 guidelines for percutaneous translurninal coronary angioplasty ). J Am Coll Cardiol,2001,37 : 2215-2239.

共引文献234

同被引文献255

引证文献21

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部